Back to Search
LECIA SEQUIST, MD
MD
Medical Oncology Physician
NPI: 1417948316IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
210902(MA)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
210902(MA)
Education
HARVARD MEDICAL SCHOOL
Class of 1999
Research & Publications (20)
The CTC-chip: an exciting new tool to detect circulating tumor cells in lung cancer patients.
PMID 19247082·J Thorac Oncol·2009
8-other
First-generation epidermal growth factor receptor tyrosine kinase inhibitors in EGFR mutation: positive non-small cell lung cancer patients.
PMID 18520299·J Thorac Oncol·2008
6-review
First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations.
PMID 18458038·J Clin Oncol·2008
3-trial
EGFR tyrosine kinase inhibitors in lung cancer: an evolving story.
PMID 17716025·Annu Rev Med·2008
6-review
Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer.
PMID 17290067·J Clin Oncol·2007
6-review
Second-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.
PMID 17405897·Oncologist·2007
6-review
Response to treatment and survival of patients with non-small cell lung cancer undergoing somatic EGFR mutation testing.
PMID 17285735·Oncologist·2007
8-other
Epidermal growth factor receptor mutation testing in the care of lung cancer patients.
PMID 16857818·Clin Cancer Res·2006
6-review
Update on epidermal growth factor receptor inhibitor development in lung cancer.
PMID 17409951·J Thorac Oncol·2006
8-other
Epidermal growth factor receptor mutations in non-small cell lung cancer: predicting clinical response to kinase inhibitors.
PMID 16115901·Clin Cancer Res·2005
8-other
Treatment of advanced non-small cell lung cancer in the elderly.
PMID 16052430·Semin Respir Crit Care Med·2005
6-review
Case records of the Massachusetts General Hospital. Case 23-2008. A 26-year-old man with back pain and a mass in the lung.
PMID 18650517·N Engl J Med·2008
5-case
Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials.
PMID 19671843·Clin Cancer Res·2009
8-other
Epidermal growth factor receptor tyrosine kinase inhibitors and depression.
PMID 19597022·J Clin Oncol·2009
8-other
Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib.
PMID 18981003·Clin Cancer Res·2008
8-other
Reduced Erlotinib sensitivity of epidermal growth factor receptor-mutant non-small cell lung cancer following cisplatin exposure: a cell culture model of second-line erlotinib treatment.
PMID 18980981·Clin Cancer Res·2008
8-other
A phase II study of oxaliplatin, pemetrexed, and bevacizumab in previously treated advanced non-small cell lung cancer.
PMID 18827612·J Thorac Oncol·2008
3-trial
Detection of mutations in EGFR in circulating lung-cancer cells.
PMID 18596266·N Engl J Med·2008
4-observational
Summary statement novel agents in the treatment of lung cancer: Fifth Cambridge Conference assessing opportunities for combination therapy.
PMID 18520291·J Thorac Oncol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 75 Francis St
Boston, MA 02115 - Phone
- (781) 487-6212
Quick Facts
- NPI
- 1417948316
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 27
- Publications
- 20
Are you this provider?
Claim Your Profile